SCHEDULE 13G/A
Statement of Beneficial Ownership
PAVmed Inc. Filed Acc 0001493152-26-022317
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Ayrton Capital LLC | 709,069 | 9.99% |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 709,069 | 9.99% |
| Waqas Khatri | 709,069 | 9.99% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-03 SCHEDULE 13G/A · Dols Scott V. 5.8%
- 2026-10-23 SCHEDULE 13G/A · Kallman Craig 4.9%
- 2026-08-13 SCHEDULE 13G/A · NAGELBERG DAVID S 8.8%
- 2026-05-15 SCHEDULE 13G · Two Seas Capital LP 9.99%
- 2026-05-14 SCHEDULE 13G · FIRST MANHATTAN CO. LLC. 9.6%
- 2026-05-11 SCHEDULE 13G/A · Ayrton Capital LLC 9.99%
- 2026-04-14 SCHEDULE 13G/A · Dana Carrera 15.3%
- 2026-04-13 SCHEDULE 13G · Scopia Holdings LLC 9.9%
- 2026-04-09 SCHEDULE 13D · Aklog Lishan 5.1%
- 2026-04-08 SCHEDULE 13G · NAGELBERG DAVID S 8.6%
- 2026-04-08 SCHEDULE 13G · Dols Scott V. 5.4%
- 2026-04-03 SCHEDULE 13G · Kallman Craig 6.0%
- 2026-04-03 SCHEDULE 13G/A · Tasso Partners, LLC 14.3%
- 2026-02-09 SCHEDULE 13D/A · PAVmed Inc. 27.5%
- 2025-10-10 SCHEDULE 13D/A · PAVmed Inc. 28.3%
- 2025-08-14 SCHEDULE 13G · Sargent Investment Group, LLC 5.8%
- 2025-05-15 SCHEDULE 13G/A · FIRST MANHATTAN CO. LLC. 4.3%
- 2025-02-28 SCHEDULE 13G · Tasso Partners, LLC 18.9%
- 2025-02-13 SCHEDULE 13G/A · Ayrton Capital LLC 9.9%
- 2024-12-12 SC 13D/A · PAVmed Inc. 52.7%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…